US Sen. Cassidy On Drug Costs: Exclusivity Based on Innovation, Reference Pricing Proposed
Executive Summary
White paper released by Sen. Cassidy, R-La., and upcoming hearing at Senate Health, Education, Labor and Pensions Committee are aimed at building consensus around legislation to lower prices.